Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study^*

References

• Masoli M, Fabian D, Holt S, et al. Global burden of asthma. May 2004. Available from: http://www.ginasthma.com/ReportItem.asp?l1=2&l2=2&intId=94 (accessed 28 July 2008)
   Google Scholar
• Busse WW. Inflammation in asthma: the cornerstone of the disease and the target of therapy. J Allergy Clin Immunol 1998;102:S17-22
   PubMed Web of Science ®Google Scholar
• Holgate ST. Pathogenesis of asthma. Clin Exp Allergy 2008;38:872-97
   PubMed Web of Science ®Google Scholar
• Fireman P. Understanding asthma pathophysiology. Allergy Asthma Proc 2003;24:79-83
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global strategy for asthma management and prevention 2007. Available from: http://www.ginasthma.org (accessed 28 July 2008)
   Google Scholar
• Bateman ED, Boushey HA, Bouquet J, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 2004;170:836-44
   PubMed Web of Science ®Google Scholar
• Malonne H, Lachman A, Van den Brande P. Impact of montelukast on symptoms in mild-to-moderate persistent asthma and exercise induced asthma: results of the ASTHMA survey. Curr Med Res Opin 2002;18:512-19
   PubMed Web of Science ®Google Scholar
• Louis R, Lau LC, Bron AO, et al. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000;161:9-16
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Efficacy of inhaled corticosteroids in asthma. J Allergy Clin Immunol 1998;102:531-8
   PubMed Web of Science ®Google Scholar
• Bisgaard H. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Allergy 2001;56 (Suppl 66):7-11
   PubMed Web of Science ®Google Scholar
• Dworski R, Fitzgerald GA, Oates JA, et al. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994;149:953-9
   PubMed Web of Science ®Google Scholar
• Peters-Golden M, Sampson AP. Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation. J Allergy Clin Immunol 2003;111 (1 Suppl):S37-42
   PubMedGoogle Scholar
• Joos S, Miksch A, Szecsenyi J, et al. Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review. Thorax 2008;63:453-62
   PubMed Web of Science ®Google Scholar
• Holgate ST, Peters-Golden M, Panettieri RA, et al. Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 2003;111 (1 Suppl):S18-34
   PubMedGoogle Scholar
• Dupont L, Potvin E, Korn D, et al. Improving asthma control in patients suboptimally controlled on inhaled steroids and long acting β2-agonists: addition of montelukast in an open-label pilot study. Curr Med Res Opin 2005;21:863-9
   PubMed Web of Science ®Google Scholar
• Bjermer L, Bisgaard H, Bousquet J, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomized, comparative trial: IMPACT. BMJ 2003;327:891-5
   PubMed Web of Science ®Google Scholar
• Vaquerizo MJ, Casan P, Castillo J, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma: CASIOPEA. Thorax 2003;58:204-10
   PubMed Web of Science ®Google Scholar
• Price DB, Hernandez D, Magyar P, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;58:211-16
   PubMed Web of Science ®Google Scholar
• Lipworth B, Jackson C. Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma. Drugs 2002;62:2315-32
   PubMed Web of Science ®Google Scholar
• Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63 (Suppl 86):8-160
   PubMed Web of Science ®Google Scholar
• Magnan A, Fourre-Jullian C, Jullian H, et al. Rhinitis alone or rhinitis plus asthma: what makes the difference? Eur Respir J 1998;12:1073-8
   PubMed Web of Science ®Google Scholar
• Price D, Zhang Q, Kocevar VS, et al. Effect of a concomitant diagnosis of allergic rhinitis on asthma-related health care use by adults. Clin Exp Allergy 2005;35:282-7
   PubMed Web of Science ®Google Scholar
• Bousquet J and the ARIA Workshop Group. Management of Allergic Rhinitis and its Impact on Asthma (ARIA) Pocket Guide. A Pocket Guide for Physicians and Nurses. 2001. J Allergy Clin Immunol 2001;108:S147-334
   Google Scholar
• Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-years follow-up study of college students. Allergy Proc 1994;15:21-5
   PubMedGoogle Scholar
• Bousquet J, Gaugris S, Kocevar VS, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy. Clin Exp Allergy 2005;35:723-7
   PubMed Web of Science ®Google Scholar
• Casale TB, Amin BV. Allergic rhinitis/asthma interrelationships. Clin Rev Allergy Immunol 2001;21:27-49
   PubMed Web of Science ®Google Scholar
• Kay AB. Allergy and allergic diseases. First of two parts. N Engl J Med 2001;344:30-7
   PubMed Web of Science ®Google Scholar
• Gaga M, Lambrou P, Papageorgiou N, et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000;30:663-9
   PubMed Web of Science ®Google Scholar
• Braunstahl GJ, Kleinjan A, Overbeek SE, et al. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000;161:2051-7
   PubMed Web of Science ®Google Scholar
• Varner AE, Lemanske RF Jr. In: Asthma and Rhinitis, 2nd edn. Oxford: Blackwell Science, 2000:1172-85
   Google Scholar
• Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol 2000;105(6 pt 2):S599-604
   PubMed Web of Science ®Google Scholar
• Vignola AM, Chanez P, Godard P, et al. Relationship between rhinitis and asthma. Allergy 1998;53:833-9
   PubMed Web of Science ®Google Scholar
• Meltzer EO. Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis base don the concept of "one linked airway disease". Ann Allergy Asthma Immunol 2000;84:176-85
   PubMed Web of Science ®Google Scholar
• Borderias L, Mincewicz G, Paggiaro PL, et al. Asthma control in patients with asthma and allergic rhinitis receiving add-on montelukast therapy for 12 months: a retrospective observational study. Curr Med Res Opin 2007;23:721-30
   PubMed Web of Science ®Google Scholar
• Juniper EF, O’Byrne PM, Guyatt GH, et al. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902-7
   PubMed Web of Science ®Google Scholar
• Juniper EF, Svensson K, Mörk AC, Ståhl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med. 2005;99:553-8
   PubMed Web of Science ®Google Scholar
• Juniper EF, Bousquet J, Abetz L, et al.; GOAL Committee. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med 2006;100:616-21
   PubMed Web of Science ®Google Scholar
• Partridge MR, van der Molen T, Myrseth SE, et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med 2006;6:13
   PubMedGoogle Scholar
• Storms W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opin Pharmacother 2007;8:2173-87
   PubMed Web of Science ®Google Scholar
• Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20:1549-58
   PubMed Web of Science ®Google Scholar
• Virchow JC, Bachert C. Efficacy and safety of montelukast in adults with asthma and allergic rhinitis. Respir Med 2006;100:1952-9
   PubMed Web of Science ®Google Scholar
• Price DB, Swern A, Tozzi CA, et al. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 2006;61:737-42
   PubMed Web of Science ®Google Scholar